In the present study, we hypothesized that SF, which decreases the synthesis of GGPP, a compound essential for RhoA activation and initiation of the RhoA/Rho-kinase pathway in HSCs, would ameliorate fibrosis and portal hypertension in rats with secondary biliary cirrhosis. This evidence concerns the gene RHOA and portal hypertension.